VenomYx
San Francisco, California, United States
About VenomYx
Venomyx is bringing antivenom into the 21st century with the world’s first toxin-specific snake antivenom. Their solution will make antivenom treatment safe, effective, and affordable for the millions of snakebite victims per year around the world that are currently underserved.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Funding stage: Seed
- Last round: Seed (Sep 2016)
- Website: venomyx.com
- Phone: +1 858 531 8336
Industries & Categories
Biotechnology, Emergency Medicine, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/venomyx-2560122 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.